2023 Q2 Form 10-Q Financial Statement

#000155837023009865 Filed on May 15, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $1.305M
YoY Change 66.26%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $15.59K
YoY Change 3.52%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $160.6K
YoY Change 115.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $86.58K
YoY Change 32.2%
Income Tax -$3.438K
% Of Pretax Income -3.97%
Net Earnings $90.02K
YoY Change 50.91%
Net Earnings / Revenue 6.9%
Basic Earnings Per Share $0.05
Diluted Earnings Per Share $0.05
COMMON SHARES
Basic Shares Outstanding 1.923M 1.923M
Diluted Shares Outstanding 1.769M

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $5.516M $24.50M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $1.409M $1.401M
YoY Change 2.75% 1.29%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $166.0M $159.8M
YoY Change 10.97% 16.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $310.1K
YoY Change 19.46%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $310.1K
YoY Change 19.46%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $460.4K
YoY Change -1.72%
Total Long-Term Liabilities $460.4K
YoY Change -1.72%
TOTAL LIABILITIES
Total Short-Term Liabilities $310.1K
Total Long-Term Liabilities $460.4K
Total Liabilities $127.5M $120.4M
YoY Change 1.01% 6.63%
SHAREHOLDERS EQUITY
Retained Earnings $24.92M $25.21M
YoY Change -2.14% -0.82%
Common Stock $19.23K $19.23K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $38.50M $39.42M
YoY Change
Total Liabilities & Shareholders Equity $166.0M $159.8M
YoY Change 10.97% 16.6%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $90.02K
YoY Change 50.91%
Depreciation, Depletion And Amortization $15.59K
YoY Change 3.52%
Cash From Operating Activities -$907.2K
YoY Change 109.73%
INVESTING ACTIVITIES
Capital Expenditures $47.55K
YoY Change -1964.71%
Acquisitions
YoY Change
Other Investing Activities -$6.314M
YoY Change -26.96%
Cash From Investing Activities -$6.362M
YoY Change -26.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 13.20M
YoY Change -3752.79%
NET CHANGE
Cash From Operating Activities -907.2K
Cash From Investing Activities -6.362M
Cash From Financing Activities 13.20M
Net Change In Cash 5.929M
YoY Change -162.79%
FREE CASH FLOW
Cash From Operating Activities -$907.2K
Capital Expenditures $47.55K
Free Cash Flow -$954.7K
YoY Change 122.03%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1769090
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1685155
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Central Index Key
EntityCentralIndexKey
0001913838
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
tmb Banking Regulation Tier1 Leverage Capital Ratio Grace Period
BankingRegulationTier1LeverageCapitalRatioGracePeriod
P6M
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1769090
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1685155
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-56459
dei Entity Registrant Name
EntityRegistrantName
VWF Bancorp, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
88-1256373
dei Entity Address Address Line1
EntityAddressAddressLine1
976 South Shannon Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Van Wert
dei Entity Address State Or Province
EntityAddressStateOrProvince
OH
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
45891
dei City Area Code
CityAreaCode
419
dei Local Phone Number
LocalPhoneNumber
238-9662
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1922924
CY2023Q1 us-gaap Cash And Due From Banks
CashAndDueFromBanks
24495645
CY2022Q2 us-gaap Cash And Due From Banks
CashAndDueFromBanks
36711842
CY2022Q2 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
1470000
CY2023Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
48821899
CY2022Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
24494410
CY2023Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
222884
CY2022Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
222884
CY2023Q1 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
78529410
CY2022Q2 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
77710188
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1401184
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1371634
CY2023Q1 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
213000
CY2022Q2 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
1012900
CY2023Q1 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
5194964
CY2022Q2 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
5112083
CY2023Q1 us-gaap Interest Receivable
InterestReceivable
366379
CY2022Q2 us-gaap Interest Receivable
InterestReceivable
219195
CY2023Q1 us-gaap Other Assets
OtherAssets
777603
CY2022Q2 us-gaap Other Assets
OtherAssets
1460297
CY2023Q1 us-gaap Assets
Assets
159800084
CY2022Q2 us-gaap Assets
Assets
149562549
CY2023Q1 us-gaap Demand Deposit Accounts
DemandDepositAccounts
29338524
CY2022Q2 us-gaap Demand Deposit Accounts
DemandDepositAccounts
26037580
CY2023Q1 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
46450734
CY2022Q2 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
48735574
CY2023Q1 us-gaap Time Deposits
TimeDeposits
43822945
CY2022Q2 us-gaap Time Deposits
TimeDeposits
35217055
CY2023Q1 us-gaap Deposits
Deposits
119612203
CY2022Q2 us-gaap Deposits
Deposits
109990209
CY2023Q1 us-gaap Advance Payments By Borrowers For Taxes And Insurance
AdvancePaymentsByBorrowersForTaxesAndInsurance
460386
CY2022Q2 us-gaap Advance Payments By Borrowers For Taxes And Insurance
AdvancePaymentsByBorrowersForTaxesAndInsurance
615735
CY2022Q2 tmb Stock Subscriptions Held In Escrow
StockSubscriptionsHeldInEscrow
15315230
CY2023Q1 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
310126
CY2022Q2 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
274269
CY2023Q1 us-gaap Liabilities
Liabilities
120382715
CY2022Q2 us-gaap Liabilities
Liabilities
126195443
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
14000000
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
14000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1922924
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
19229
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
17875071
CY2023Q1 tmb Employee Stock Ownership Plan Shares Acquired
EmployeeStockOwnershipPlanSharesAcquired
1461422
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
25213816
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
25461865
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2229325
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2094759
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
39417369
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
23367106
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
159800084
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
149562549
CY2023Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
713572
CY2022Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
677875
us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
2125558
us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
2040931
CY2023Q1 us-gaap Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
349880
CY2022Q1 us-gaap Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
86595
us-gaap Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
860578
us-gaap Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
242938
CY2023Q1 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
241433
CY2022Q1 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
20360
us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
550789
us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
73979
CY2023Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
1304885
CY2022Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
784830
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
3536925
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
2357848
CY2023Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
160571
CY2022Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
74683
us-gaap Interest Expense Deposits
InterestExpenseDeposits
316752
us-gaap Interest Expense Deposits
InterestExpenseDeposits
253692
us-gaap Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesLongTerm
22
us-gaap Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesLongTerm
1
CY2023Q1 us-gaap Interest Expense
InterestExpense
160571
CY2022Q1 us-gaap Interest Expense
InterestExpense
74683
us-gaap Interest Expense
InterestExpense
316774
us-gaap Interest Expense
InterestExpense
253693
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1144314
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
710147
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
3220151
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
2104155
CY2023Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
1144314
CY2022Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
710147
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
3220151
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
2104155
CY2023Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
28024
CY2022Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
26602
us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
82881
us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
81365
CY2023Q1 us-gaap Noninterest Income Other
NoninterestIncomeOther
20762
CY2022Q1 us-gaap Noninterest Income Other
NoninterestIncomeOther
26812
us-gaap Noninterest Income Other
NoninterestIncomeOther
71753
us-gaap Noninterest Income Other
NoninterestIncomeOther
80901
CY2023Q1 us-gaap Noninterest Income
NoninterestIncome
48786
CY2022Q1 us-gaap Noninterest Income
NoninterestIncome
53414
us-gaap Noninterest Income
NoninterestIncome
154634
us-gaap Noninterest Income
NoninterestIncome
162266
CY2023Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
500699
CY2022Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
357419
us-gaap Labor And Related Expense
LaborAndRelatedExpense
1293089
us-gaap Labor And Related Expense
LaborAndRelatedExpense
1064369
CY2023Q1 tmb Pension Plan Withdrawal
PensionPlanWithdrawal
121820
tmb Pension Plan Withdrawal
PensionPlanWithdrawal
1051820
CY2023Q1 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
44000
CY2022Q1 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
35000
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
114000
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
130500
CY2023Q1 us-gaap Occupancy Net
OccupancyNet
111523
CY2022Q1 us-gaap Occupancy Net
OccupancyNet
50384
us-gaap Occupancy Net
OccupancyNet
224872
us-gaap Occupancy Net
OccupancyNet
140411
CY2023Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
67592
CY2022Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
61294
us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
192678
us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
175524
CY2023Q1 us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
41195
CY2022Q1 us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
38824
us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
118845
us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
108604
CY2023Q1 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
9000
CY2022Q1 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
8400
us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
27900
us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
24700
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
95510
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
57848
us-gaap Professional Fees
ProfessionalFees
431953
us-gaap Professional Fees
ProfessionalFees
130853
us-gaap Debt Securities Available For Sale Gain Loss
DebtSecuritiesAvailableForSaleGainLoss
-291198
CY2023Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
115179
CY2022Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
88900
us-gaap Other Noninterest Expense
OtherNoninterestExpense
281241
us-gaap Other Noninterest Expense
OtherNoninterestExpense
280006
CY2023Q1 us-gaap Noninterest Expense
NoninterestExpense
1106518
CY2022Q1 us-gaap Noninterest Expense
NoninterestExpense
698069
us-gaap Noninterest Expense
NoninterestExpense
3736398
us-gaap Noninterest Expense
NoninterestExpense
2346165
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
86582
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
65492
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-361613
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-79744
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3438
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5840
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-113564
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-31606
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
90020
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
59652
us-gaap Net Income Loss
NetIncomeLoss
-248049
us-gaap Net Income Loss
NetIncomeLoss
-48138
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1769090
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1685155
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
90020
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
59652
us-gaap Net Income Loss
NetIncomeLoss
-248049
us-gaap Net Income Loss
NetIncomeLoss
-48138
CY2023Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent
562701
CY2022Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent
-1475929
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent
-170337
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent
-1812396
us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
291198
CY2023Q1 us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
118167
CY2022Q1 us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
-309945
us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
-35771
us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
-319452
CY2023Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
444534
CY2022Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-1165984
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-134566
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-1201746
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
534554
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1106332
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-382615
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1249884
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
38882815
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
90020
CY2023Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
444534
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
39417369
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
25252424
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
59652
CY2022Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-1165984
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
24146092
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
23367106
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
16326487
us-gaap Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
106391
us-gaap Net Income Loss
NetIncomeLoss
-248049
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-134566
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
39417369
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
25395976
us-gaap Net Income Loss
NetIncomeLoss
-48138
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-1201746
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
24146092
us-gaap Profit Loss
ProfitLoss
-248049
us-gaap Profit Loss
ProfitLoss
-48138
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
45956
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
48917
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
47657
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
63956
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
111094
us-gaap Debt Securities Available For Sale Gain Loss
DebtSecuritiesAvailableForSaleGainLoss
-291198
us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
82881
us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
81365
us-gaap Employee Benefits And Share Based Compensation Noncash
EmployeeBenefitsAndShareBasedCompensationNoncash
106391
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
147184
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
39294
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-643228
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
531716
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
476212
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-296442
us-gaap Proceeds From Payments For In Interest Bearing Deposits In Banks
ProceedsFromPaymentsForInInterestBearingDepositsInBanks
1470000
us-gaap Proceeds From Payments For In Interest Bearing Deposits In Banks
ProceedsFromPaymentsForInInterestBearingDepositsInBanks
2450000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
27426997
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
11594684
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
9708443
tmb Proceeds From Maturities Prepayment And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentAndCallsOfAvailableForSaleSecurities
2881515
tmb Proceeds From Maturities Prepayment And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentAndCallsOfAvailableForSaleSecurities
3329514
us-gaap Proceeds From Payments For Long Term Loans For Related Parties
ProceedsFromPaymentsForLongTermLoansForRelatedParties
-819222
us-gaap Proceeds From Payments For Long Term Loans For Related Parties
ProceedsFromPaymentsForLongTermLoansForRelatedParties
-4280012
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
75507
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11031
us-gaap Proceeds From Sale Of Federal Home Loan Bank Stock
ProceedsFromSaleOfFederalHomeLoanBankStock
799900
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-23170311
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-397770
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
9621994
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
11251431
us-gaap Increase Decrease In Advance Payments By Borrowers For Taxes And Insurance
IncreaseDecreaseInAdvancePaymentsByBorrowersForTaxesAndInsurance
-155349
us-gaap Increase Decrease In Advance Payments By Borrowers For Taxes And Insurance
IncreaseDecreaseInAdvancePaymentsByBorrowersForTaxesAndInsurance
-110874
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1011257
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10477902
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
11140557
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12216197
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10446345
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36711842
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11660839
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24495645
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22107184
us-gaap Interest Paid Net
InterestPaidNet
288506
us-gaap Interest Paid Net
InterestPaidNet
253677
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
30000
us-gaap Stock Issued1
StockIssued1
15315230
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">Material estimates that are particularly susceptible to significant change relate to the determination of the allowance for loan losses, valuation of real estate acquired in connection with foreclosures or in satisfaction of loans, valuation of deferred tax assets and fair values of financial instruments.</p>
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
90020
us-gaap Net Income Loss
NetIncomeLoss
-248049
CY2023Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
1922924
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
1831690
CY2023Q1 us-gaap Weighted Average Number Of Shares Employee Stock Ownership Plan Shares Not Committed To Be Released
WeightedAverageNumberOfSharesEmployeeStockOwnershipPlanSharesNotCommittedToBeReleased
153834
us-gaap Weighted Average Number Of Shares Employee Stock Ownership Plan Shares Not Committed To Be Released
WeightedAverageNumberOfSharesEmployeeStockOwnershipPlanSharesNotCommittedToBeReleased
146535
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1769090
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1685155
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2023Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
51643783
us-gaap Available For Sale Debt Securities Gross Unrealized Gain
AvailableForSaleDebtSecuritiesGrossUnrealizedGain
77900
us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
2899784
CY2023Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
48821899
CY2023Q1 us-gaap Financing Receivable Before Allowance For Credit Loss And Fee
FinancingReceivableBeforeAllowanceForCreditLossAndFee
81282899
CY2022Q2 us-gaap Financing Receivable Before Allowance For Credit Loss And Fee
FinancingReceivableBeforeAllowanceForCreditLossAndFee
82267595
CY2023Q1 us-gaap Financing Receivable Loan In Process
FinancingReceivableLoanInProcess
2515248
CY2022Q2 us-gaap Financing Receivable Loan In Process
FinancingReceivableLoanInProcess
4324320
CY2023Q1 us-gaap Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount
FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount
-15357
CY2022Q2 us-gaap Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount
FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount
-10203
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
222884
CY2022Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
27146004
CY2022 us-gaap Available For Sale Debt Securities Gross Unrealized Gain
AvailableForSaleDebtSecuritiesGrossUnrealizedGain
8405
CY2022 us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
2659999
CY2022Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
24494410
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
6422358
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
5994047
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
3140101
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
2816304
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
2002464
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
1653951
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
11564923
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
10464302
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
40078860
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
38357597
CY2023Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
51643783
CY2023Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
48821899
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0
CY2023Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0
CY2023Q1 tmb Investments In Debt Securities Reported Less Than Historical Cost Fair Value
InvestmentsInDebtSecuritiesReportedLessThanHistoricalCostFairValue
33942000
CY2022Q2 tmb Investments In Debt Securities Reported Less Than Historical Cost Fair Value
InvestmentsInDebtSecuritiesReportedLessThanHistoricalCostFairValue
22517000
tmb Investments In Debt Securities Reported Less Than Historical Cost Percentage
InvestmentsInDebtSecuritiesReportedLessThanHistoricalCostPercentage
0.695
CY2022 tmb Investments In Debt Securities Reported Less Than Historical Cost Percentage
InvestmentsInDebtSecuritiesReportedLessThanHistoricalCostPercentage
0.919
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
13958613
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
216995
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
19983534
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
2682789
CY2023Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
33942147
CY2023Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
2899784
CY2022Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
15865151
CY2022Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
1469051
CY2022Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
6651409
CY2022Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
1190948
CY2022Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
22516560
CY2022Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
2659999
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
222884
CY2023Q1 us-gaap Notes Receivable Net
NotesReceivableNet
78529410
CY2022Q2 us-gaap Notes Receivable Net
NotesReceivableNet
77710188
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
222884
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
222884
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
222884
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
222884
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
222884
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
222884
CY2021Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
222884
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
222884
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
629
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
222255
CY2023Q1 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
262784
CY2023Q1 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
81020115
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
2734
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
220150
CY2022Q2 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
359263
CY2022Q2 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
81908332
CY2023Q1 us-gaap Financing Receivable Before Allowance For Credit Loss And Fee
FinancingReceivableBeforeAllowanceForCreditLossAndFee
81282899
CY2022Q2 us-gaap Financing Receivable Before Allowance For Credit Loss And Fee
FinancingReceivableBeforeAllowanceForCreditLossAndFee
82267595
CY2022Q2 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
133681
CY2023Q1 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
163007
CY2023Q1 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
163007
CY2023Q1 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
262784
CY2023Q1 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
262784
CY2023Q1 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
629
CY2022Q2 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
296204
CY2022Q2 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
296204
CY2022Q2 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
359263
CY2022Q2 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
359263
CY2022Q2 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
2734
CY2023Q1 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
295248000
CY2023Q1 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
3853000
CY2022Q1 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
222847000
CY2022Q1 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
2266000
us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
306842000
us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
7446000
us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
235563000
us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
7057000
CY2023Q1 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
262784
CY2022Q2 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
225582
us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
0
CY2022 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
0
us-gaap Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
0
CY2022 us-gaap Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
0
CY2023Q1 us-gaap Tier One Leverage Capital To Average Assets
TierOneLeverageCapitalToAverageAssets
1
CY2023Q1 us-gaap Tier One Leverage Capital Required To Be Well Capitalized To Average Assets
TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets
0.2269
CY2022Q2 us-gaap Tier One Leverage Capital Required To Be Well Capitalized To Average Assets
TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets
0.1754
CY2023Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
0
CY2023Q1 us-gaap Contractual Obligation
ContractualObligation
10547000
CY2022Q2 us-gaap Contractual Obligation
ContractualObligation
6735000
CY2023Q1 tmb Pension Plan Withdrawal
PensionPlanWithdrawal
122000
tmb Pension Plan Withdrawal
PensionPlanWithdrawal
1052000
CY2023Q1 us-gaap Defined Benefit Plan Fair Value Of Plan Assets
DefinedBenefitPlanFairValueOfPlanAssets
4978000
CY2023Q1 us-gaap Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
5008000

Files In Submission

Name View Source Status
0001558370-23-009865-index-headers.html Edgar Link pending
0001558370-23-009865-index.html Edgar Link pending
0001558370-23-009865.txt Edgar Link pending
0001558370-23-009865-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
vwfb-20230331_cal.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vwfb-20230331.xsd Edgar Link pending
vwfb-20230331x10q.htm Edgar Link pending
vwfb-20230331xex31d1.htm Edgar Link pending
vwfb-20230331xex31d2.htm Edgar Link pending
vwfb-20230331xex32.htm Edgar Link pending
vwfb-20230331_def.xml Edgar Link unprocessable
vwfb-20230331_pre.xml Edgar Link unprocessable
vwfb-20230331x10q_htm.xml Edgar Link completed
vwfb-20230331_lab.xml Edgar Link unprocessable